Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns

dc.contributor.author
Sanchez-Mut, Jose Vicente
dc.contributor.author
Heyn, Holger
dc.contributor.author
Vidal, Enrique
dc.contributor.author
Moran, Sebastian
dc.contributor.author
Sayols, Sergi
dc.contributor.author
Delgado-Morales, Raul
dc.contributor.author
Schultz, Matthew D.
dc.contributor.author
Ansoleaga, Belén
dc.contributor.author
Garcia Esparcia, Paula
dc.contributor.author
Pons-Espinal, Meritxell
dc.contributor.author
Lagran, M. M. de
dc.contributor.author
Dopazo, Joaquín
dc.contributor.author
Rabano, Alberto
dc.contributor.author
Avila, Jesús
dc.contributor.author
Dierssen, Mara
dc.contributor.author
Lott, I.
dc.contributor.author
Ferrer, Isidro (Ferrer Abizanda)
dc.contributor.author
Ecker, Joseph R.
dc.contributor.author
Esteller, Manel
dc.date.issued
2017-05-22T11:43:05Z
dc.date.issued
2017-05-22T11:43:05Z
dc.date.issued
2016-01-19
dc.date.issued
2017-05-22T11:43:05Z
dc.identifier
2158-3188
dc.identifier
https://hdl.handle.net/2445/111398
dc.identifier
662706
dc.identifier
26784972
dc.description.abstract
Different neurodegenerative disorders often show similar lesions, such as the presence of amyloid plaques, TAU-neurotangles and synuclein inclusions. The genetically inherited forms are rare, so we wondered whether shared epigenetic aberrations, such as those affecting DNA methylation, might also exist. The studied samples were gray matter samples from the prefrontal cortex of control and neurodegenerative disease-associated cases. We performed the DNA methylation analyses of Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease and Alzheimer-like neurodegenerative profile associated with Down's syndrome samples. The DNA methylation landscapes obtained show that neurodegenerative diseases share similar aberrant CpG methylation shifts targeting a defined gene set. Our findings suggest that neurodegenerative disorders might have similar pathogenetic mechanisms that subsequently evolve into different clinical entities. The identified aberrant DNA methylation changes can be used as biomarkers of the disorders and as potential new targets for the development of new therapies.
dc.format
8 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Nature Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/tp.2015.214
dc.relation
Translational Psychiatry, 2016, vol. 6, p. e718
dc.relation
https://doi.org/10.1038/tp.2015.214
dc.relation
info:eu-repo/grantAgreement/EC/FP7/238242/EU//DISCHROM
dc.relation
info:eu-repo/grantAgreement/EC/FP7/278486/EU//DEVELAGE
dc.rights
cc-by-nc-nd (c) Sanchez-Mut, Jose Vicente et al., 2016
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Fisiològiques)
dc.subject
Epigènesi
dc.subject
ADN
dc.subject
Metilació
dc.subject
Malalties neurodegeneratives
dc.subject
Sistema nerviós
dc.subject
Epigenesis
dc.subject
DNA
dc.subject
Methylation
dc.subject
Neurodegenerative Diseases
dc.subject
Nervous system
dc.title
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.